SMARCB1 and neoplasm: These findings are in line with the concept that in contrast to the complete absence of SMARCB1 expression in MRT, altered SMARCB1 proteins with modified activity and reduced expression are responsible for a mosaic SMARCB1 expression pattern in the tumours of patients with schwannomatosis [364].